Internal Medicine, Infectious Disease · Newark, NJ
NPI
1366411076
Since 2006
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
5
Medicare group memberships
Hospitals
1
Hospital affiliations
268 Dr Martin Luther King Jr Blvd
Newark, NJ, 07102
Phone (973) 364-2682
Groups this clinician bills Medicare through
Medicare paid, 2024
$43K
536 services
Medicare patients, 2024
195
Average age 69
Drug cost, 2024
$11.8M
4,463 prescriptions
Company payments, 2025
$291K
From 9 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jihad Slim was code 99232 (hospital e&m - subsequent), 156 times for 67 patients. In total Jihad Slim billed 536 services in 14 codes, and Medicare paid $43K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-05-30.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 156 | 67 | $66.41 | $10K |
| 99213 Office E&M - Established | Office | 148 | 61 | $62.58 | $9,261 |
| 99214 Office E&M - Established | Office | 96 | 57 | $95.16 | $9,136 |
| 99222 Hospital E&M - Initial | Facility | 88 | 71 | $110.25 | $9,702 |
| 99441 Telephone Services | Office | 13 | 12 | $41.51 | $540 |
By year: 2022 $44K for 606 services; 2023 $42K for 560 services; 2024 $43K for 536 services.
Medicare prescription drug claims, 2024
In 2024, the drug Jihad Slim prescribed most often to Medicare patients was Dovato (Dolutegravir Sodium/Lamivudine), with 798 prescriptions and refills. In total Jihad Slim wrote 4,463 Medicare prescriptions that cost $11.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Dovato Dolutegravir Sodium/Lamivudine | 798 | 809 | 82 | $2.3M |
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 708 | 714 | 79 | $2.8M |
| Tivicay Dolutegravir Sodium | 438 | 438 | 51 | $1.0M |
| Pifeltro Doravirine | 437 | 439 | 46 | $745K |
| Atorvastatin Calcium Generic | 174 | 259 | 40 | $614 |
| Symtuza Darunavir/Cob/Emtri/Tenof Alaf | 121 | 129 | 17 | $573K |
| Odefsey Emtricitab/Rilpiviri/Tenof Ala | 113 | 113 | 11 | $416K |
| Amlodipine Besylate Generic | 83 | 105 | 16 | $166 |
| Juluca Dolutegravir/Rilpivirine | 78 | 80 | 11 | $260K |
| Losartan Potassium Generic | 75 | 99 | 17 | $261 |
| Rukobia Fostemsavir Tromethamine | 72 | 72 | Under 11 | $638K |
| Epclusa Sofosbuvir/Velpatasvir | 63 | 63 | 23 | $1.4M |
| Prezcobix Darunavir/Cobicistat | 62 | 62 | Under 11 | $148K |
| Rosuvastatin Calcium Generic | 61 | 79 | 12 | $479 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 54 | 54 | Under 11 | $1,208 |
Brand drugs: 3,218 claims; generic drugs: - claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jihad Slim $291K ($291K in general payments such as food, travel and fees) from 9 companies. The largest payer was ViiV Healthcare Company with $92K.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.